Concentrix Corp — Director's Dealing 2022

Jan 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2022-01-03

Reporting Person: POLK DENNIS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-03	Common Stock	M	5000	$37.94	Acquired	32532	Direct
2022-01-03	Common Stock	S	1604	$175.396	Disposed	30928	Direct
2022-01-03	Common Stock	S	1496	$176.331	Disposed	29432	Direct
2022-01-03	Common Stock	S	1800	$177.486	Disposed	27632	Direct
2022-01-03	Common Stock	S	100	$179.22	Disposed	27532	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-03	Employee Stock Option (Right to Buy)	$37.94	M	5000	Disposed	2028-10-11	Common Stock (5000.0)	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.00 to $176.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.08 to $177.97, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.